Creative Planning’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Creative Planning’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-37,310	Closed	-$121K	–	2679
2021 Q1	$121K	Buy	+37,310	New	+$124K	﹤0.01%	2216
2017 Q2	–	Sell	-4,000	Closed	-$13K	–	4897
2017 Q1	$13K	Buy	+4,000	New	+$9.84K	﹤0.01%	3442
2015 Q2	–	Sell	-300	Closed	-$4K	–	3230
2015 Q1	$4K	Hold	300	–	–	﹤0.01%	3672
2014 Q4	$5K	Hold	300	–	–	﹤0.01%	3522
2014 Q3	$4K	Hold	300	–	–	﹤0.01%	3426
2014 Q2	$4K	Hold	300	–	–	﹤0.01%	3337
2014 Q1	$4K	Buy	+300	New	+$4.03K	﹤0.01%	3201

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

Creative Planning's INFI Position: Q2 2021 in Review

Creative Planning sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2021, closing a stake of 37,310 shares — an estimated $121K sold.

Creative Planning first reported a position in INFI in Q1 2014 and held it in 7 quarters. The position peaked at $121K in Q1 2021. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

Creative Planning reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
Creative Planning sold 37,310 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $121K.
Creative Planning first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 7 quarters.
Creative Planning's Infinity Pharmaceuticals, Inc. position peaked at $121K in Q1 2021.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.